» Articles » PMID: 20233720

Involvement of Oxidative Stress in the Relapse of Acute Myeloid Leukemia

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2010 Mar 18
PMID 20233720
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

The aims of the present study were to determine the level of oxidative stress and the salient factors leading to the relapse of acute myeloid leukemia (AML). Oxidative stress-related parameters and the expressions of specific genes were monitored in 102 cases of AML during a pretreatment period from a primary status to a relapse status. In addition, age-matched healthy subjects were classified as controls. The activities of adenosine deaminase and xanthine oxidase were higher in the relapse condition, whereas those of glutathione peroxidase, monoamine oxidase, and superoxide dismutase, and the total antioxidant capacity (T-AOC) were lower in the primary condition and in controls. Of particular note, levels of advanced oxidation protein products, malondialdehyde, and 8-hydroxydeoxyguanosine were also significantly higher in relapse patients. Furthermore, real-time PCR with SYBR Green revealed that the expression levels of human thioredoxin (TRX) and indoleamine 2,3-dioxygenase were increased in relapse patients. Pearson correlation analysis revealed that the T-AOC was positively correlated with GSH but negatively correlated with 8-OHdG, TRX, and indoleamine 2,3-dioxygenase. Linear regression showed that a low T-AOC and up-regulated TRX expression were the independent factors correlated with relapse. A strong association between oxidative stress and the incidence of disease relapse was observed, which has potential prognosis implications. These results indicate that oxidative stress is a crucial feature of AML and probably affects the development and relapse of AML.

Citing Articles

Role of reactive oxygen species in myelodysplastic syndromes.

Jing Q, Zhou C, Zhang J, Zhang P, Wu Y, Zhou J Cell Mol Biol Lett. 2024; 29(1):53.

PMID: 38616283 PMC: 11017617. DOI: 10.1186/s11658-024-00570-0.


A Preliminary Evaluation of Advanced Oxidation Protein Products (AOPPs) as a Potential Approach to Evaluating Prognosis in Early-Stage Breast Cancer Patients and Its Implication in Tumour Angiogenesis: A 7-Year Single-Centre Study.

Napiorkowska-Mastalerz M, Wybranowski T, Bosek M, Kruszewski S, Rhone P, Ruszkowska-Ciastek B Cancers (Basel). 2024; 16(5).

PMID: 38473424 PMC: 10930735. DOI: 10.3390/cancers16051068.


Reactive oxygen species and its role in pathogenesis and resistance to therapy in acute myeloid leukemia.

Khorashad J, Rizzo S, Tonks A Cancer Drug Resist. 2024; 7:5.

PMID: 38434766 PMC: 10905166. DOI: 10.20517/cdr.2023.125.


The Peptide Salamandrin-I Modulates Components Involved in Pyroptosis and Induces Cell Death in Human Leukemia Cell Line HL-60.

Silva-Carvalho A, Oliveira N, Machado J, Moreira D, Brand G, Leite J Pharmaceutics. 2023; 15(7).

PMID: 37514049 PMC: 10384876. DOI: 10.3390/pharmaceutics15071864.


The Molecular Context of Oxidant Stress Response in Cancer Establishes ALDH1A1 as a Critical Target: What This Means for Acute Myeloid Leukemia.

Dancik G, Varisli L, Vlahopoulos S Int J Mol Sci. 2023; 24(11).

PMID: 37298333 PMC: 10253856. DOI: 10.3390/ijms24119372.


References
1.
Hofer S, Rosenhagen C, Nakamura H, Yodoi J, Bopp C, Zimmermann J . Thioredoxin in human and experimental sepsis. Crit Care Med. 2009; 37(7):2155-9. DOI: 10.1097/CCM.0b013e31819fff67. View

2.
Montesinos J, Sanchez-Valle E, Flores-Figueroa E, Martinez-Jaramillo G, Flores-Guzman P, Miranda-Peralta E . Deficient proliferation and expansion in vitro of two bone marrow cell populations from patients with acute myeloid leukemia in response to hematopoietic cytokines. Leuk Lymphoma. 2006; 47(7):1379-86. DOI: 10.1080/10428190500465424. View

3.
Zhou F, Zhang W, Wei Y, Zhou D, Su Z, Meng X . The changes of oxidative stress and human 8-hydroxyguanine glycosylase1 gene expression in depressive patients with acute leukemia. Leuk Res. 2006; 31(3):387-93. DOI: 10.1016/j.leukres.2006.07.014. View

4.
Hou D, Muller A, Sharma M, DuHadaway J, Banerjee T, Johnson M . Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses. Cancer Res. 2007; 67(2):792-801. DOI: 10.1158/0008-5472.CAN-06-2925. View

5.
Al-Gayyar M, Eissa L, Rabie A, El-Gayar A . Measurements of oxidative stress status and antioxidant activity in chronic leukaemia patients. J Pharm Pharmacol. 2007; 59(3):409-17. DOI: 10.1211/jpp.59.3.0011. View